# Immune Evasion Resistance Report - Hiv

## Summary

Total epitopes analyzed: 4
Evasion-resistant epitopes (score > 0.6): 0
High-risk epitopes (susceptibility > 0.7): 0
Average resistance score: 0.392
Average evasion susceptibility: 0.257

## Hiv Immune Evasion Profile

**Primary Evasion Mechanisms:**
- Immune escape mutations
- Antigen loss variants
- MHC Class I downregulation

**Microenvironment:** chronic_inflammation
**Checkpoint Pathways:** pd1_pdl1, ctla4

## Top 15 Evasion-Resistant Epitopes

| Rank | Peptide | Resistance Score | Susceptibility | Conservation | Mutation Freq |
|------|---------|------------------|----------------|--------------|---------------|

## Evasion Mechanism Analysis

### Immune escape mutations

- Susceptible epitopes: 0
- Resistant epitopes: 4
- Recommended resistance strategies: conserved_regions, broad_targeting

### Antigen loss variants

- Susceptible epitopes: 2
- Resistant epitopes: 2
- Recommended resistance strategies: conserved_epitopes, multi_epitope_targeting

### MHC Class I downregulation

- Susceptible epitopes: 4
- Resistant epitopes: 0
- Recommended resistance strategies: mhc_ii_targeting, nk_cell_activation

## Vaccine Strategy Recommendations

### Primary Epitopes (0 selected)

### Combination Therapy Recommendations

**vaccine_plus_latency_reversal**
- Components: vaccine, HDAC_inhibitors, PKC_agonists
- Rationale: Activate latent virus for immune targeting

### Delivery Optimization

- Route: intramuscular
- Formulation: mhc_ii_targeting
- Timing: prime_boost

## Key Recommendations

Limited evasion-resistant epitopes. Strongly recommend combination with checkpoint inhibitors and adjuvants.

Implementation priorities:
1. Focus on epitopes with resistance score > 0.6
2. Implement recommended combination therapies
3. Use appropriate adjuvants for disease-specific evasion mechanisms
4. Consider optimized delivery strategies
5. Plan for monitoring of immune escape variants
6. Validate resistance predictions in relevant disease models
